B. Braun Medical S.A. has ordered two PrepLog® systems from Pharmacolog. The systems will be equipped with modified software and delivery is scheduled for the end of March.
B. Braun Medical S.A. in Spain and Pharmacolog signed a distribution agreement regarding the Spanish market in February 2018. The companies have subsequently collaborated to further develop PrepLog® into a fully integrated solution to operate in B. Braun’s chemotherapy management system. During 2019, PrepLog® was evaluated at Hospital Sant Pau in Barcelona with good results. B. Braun Medical S.A. in Spain have now ordered two PrepLog® systems from Pharmacolog. The systems will be delivered with a modified software to conform to specific Spanish requirements. Completion of the software adjustments and delivery of the systems is planned for late March 2020. The order value amounts to around SEK 600,000.
Mats Högberg, CEO, comments: “We are delighted to continue our collaboration with B. Braun, a leading company in drug management. Their Onco Safety Remote Control is a unique system for safer and more efficient handling of chemotherapy drugs. Together with PrepLog®, we set a whole new standard when it comes to quality control of cytotoxic preparations. For the first time, a pharmacist can immediately verify that the prescribed medication is correct.”
For more information contact:
Mats Högberg, CEO
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on January 27, 2020 at 20:30
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Download as PDF